 OncoCyte Corporation NASDAQ:OCX Q3 2022 Results Conference Call November 10, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Relations Ronnie Andrews - President and Chief Executive Officer Anish John - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Mark Massaro - BTIG Thomas Flaten - Lake Street Mason Carrico - Stephens Bruce Jackson - Benchmark Company Operator Good day, and welcome to the OncoCyte Conference Call to discuss the Third Quarter 2022 Financial Results. Todays call is being recorded. 